Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Edesa Biotech, Inc. (EDSA) had Return on Equity of -1355.39% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-5.41M |
|
-- |
|
-- |
|
$5.52M |
|
$-5.52M |
|
$0.11M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.41M |
|
$-5.52M |
|
$-5.49M |
|
9.01M |
|
9.01M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$10.78M |
|
-- |
|
$1.94M |
|
$12.72M |
|
$3.91M |
|
-- |
|
-- |
|
$3.91M |
|
$0.40M |
|
$6.91M |
|
$8.81M |
|
9.63M |
|
| Cash Flow Statement Financials | |
$-7.19M |
|
-- |
|
$6.79M |
|
$10.79M |
|
$10.33M |
|
$-0.46M |
|
$1.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-1355.39% |
-78.27% |
|
-42.51% |
|
-61.37% |
|
$0.91 |
|
$-0.80 |
|
$-0.80 |
|